A recent New York Times investigation has put Elon Musk’s alleged drug use under renewed scrutiny, reporting that the billionaire regularly traveled with a pill organizer containing about tablets, some marked as Adderall. The article claims Musk’s consumption of stimulants and other substances—including ketamine, ecstasy, and psychedelic mushrooms—was “far more serious than previously known” during his time as a prominent figure in the Trump administration and throughout the 2024 presidential campaign.
The Times cited photographic evidence and multiple witnesses who reportedly saw Musk’s medication box. Adderall, a prescription stimulant used to treat ADHD, was among the pills identified, raising questions about the extent and purpose of Musk’s usage.
Musk has strongly denied the allegations, calling the Times’ reporting “completely fabricated.” He acknowledged experimenting with prescription ketamine in the past to help with mental health struggles but insisted he has not used it recently. “I am NOT using drugs! The New York Times is completely fabricating this,” Musk wrote on X, the social platform he owns.
During a White House press briefing, Fox News correspondent Peter Doocy attempted to question Musk about the Times’ report. Musk sidestepped the inquiry, instead criticizing the Times’ journalistic integrity and referencing unrelated controversies involving the publication.
The New York Times has stood by its reporting, stating that Musk was given multiple opportunities to respond before publication and emphasizing that their article was based on interviews, documents, and photographic proof.
As the debate continues, the story has fueled public speculation about Musk’s personal habits and their potential impact on his leadership at Tesla, SpaceX, and beyond.
